Inflammatix Selected for ARPA-H CIRCLE Program to Bring Precision Immune Medicine to the ICU

Company will develop the bedside immune-state readout for a Stanford Medicine–led team awarded $41 million in ARPA-H’s CIRCLE critical care program SUNNYVALE, Calif. — October 8, 2026 — Inflammatix, Inc., a precision diagnostics company focused on measurement of the host immune response, today announced its selection as the commercialization collaborator and bedside platform developer for […] The post Inflammatix Selected for ARPA-H CIRCLE Program to Bring Precision Immune Medicine to the ICU appeared first on Inflammatix .